Utilization of breast cancer risk prediction models by cancer genetic counselors in clinical practice predominantly in the United States

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries

(2017) Anne Brédart et al.   Familial Cancer

BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?

(2017) Bárbara Alemar et al.   PLoS One

BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing

(2015) Z. I. Mitri et al.   ONCOLOGIST

Protein-truncating variants in moderate-risk breast cancer susceptibility genes: A meta-analysis of high-risk case-control screening studies

(2015) Fatima Aloraifi et al.   Cancer Genetics

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

(2015) Andrea Desmond et al.   JAMA Oncology

Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic Counselors

(2011) Bronson D. Riley et al.   Journal of Genetic Counseling

A Clinical Scoring System for Selection of Patients for PTEN Mutation Testing Is Proposed on the Basis of a Prospective Study of 3042 Probands

(2010) Min-Han Tan et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Estimating CDKN2A Carrier Probability and Personalizing Cancer Risk Assessments in Hereditary Melanoma Using MelaPRO

(2010) W. Wang et al.   CANCER RESEARCH

Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study

(2010) Noralane M. Lindor et al.   Familial Cancer

Clinical application of breast cancer risk assessment models

(2010) Kaylene Ready et al.   Future Oncology

Comparing Breast Cancer Risk Assessment Models

(2010) Mitchell H. Gail et al.   JNCI-Journal of the National Cancer Institute

Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models

(2010) E. Amir et al.   JNCI-Journal of the National Cancer Institute

A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example

(2009) Leila Mohammadi et al.   BMC CANCER

Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry

(2009) A. W. Kurian et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection

(2009) J. J. T. van Harssel et al.   Familial Cancer

Selecting a BRCA risk assessment model for use in a familial cancer clinic

(2008) Seema M Panchal et al.   BMC Medical Genetics

Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?

(2008) Catharina E. Jacobi et al.   BREAST CANCER RESEARCH AND TREATMENT